Sinonasal tract and nasopharyngeal melanomas - A clinicopathologic study of 115 cases with a proposed staging system

被引:202
作者
Thompson, LDR
Wieneke, JA
Miettinen, M
机构
[1] Armed Forces Inst Pathol, Dept Endocrine & Otorhinolaryngol Head & Neck Pat, Washington, DC 20306 USA
[2] Armed Forces Inst Pathol, Dept Soft Tissue Pathol, Washington, DC 20306 USA
关键词
malignant mucosal melanoma; sinuses; nasal cavity; staging; prognosis; histology; immunohistochemistry; TNM classification;
D O I
10.1097/00000478-200305000-00004
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Primary sinonasal tract mucosal malignant melanomas are Uncommon tumors that Lire frequently misclassified. resulting, in inappropriate clinical management. A total of 115 cases of sinonasal tract mucosal malignant melanoma included 59 females and 56 males. 13-93 years of age (mean 64.3 years). Patients presented most frequently with epistaxis (n = 52). mass (n = 42). and/or nasal obstruction (n = 34) present for a mean of 8.2 months. The majority of tumors involved the nasal cavity (n = 34). septum alone, or a combination of the nasal cavity and sinuses (n = 39) with a mean size of 2.4 cm. Histologically, the tumors were composed of a variety of cell types (epithelioid. spindled. undifferentiated). frequently arranged in a peritheliomatous distribution in = 39). immunohistochemical Studies confirmed the diagnosis of sinonasal tract mucosal malignant melanomas with positive reactions for S-100 protein, tyrosinase. HMB-45. melan A, and microphthalmia transcription factor. Sinonasal tract mucosal malignant melanomas need to be considered in the differential diagnosis of most sinonasal malignancies. particularly carcinoma. lymphoma. sarcoma, and olfactory neuroblastoma. Surgery accompanied by radiation and/or chemotherapy was generally used. The majority of patients developed a recurrence (n = 79). with 75 patients dying with disseminated disease (mean 2.3 years), whereas 40 patients are either alive or had died of unrelated causes (mean 13.9 years), A TNM-type classification separated by anatomic site of involvement and metastatic disease is proposed to predict biologic behavior.
引用
收藏
页码:594 / 611
页数:18
相关论文
共 73 条
  • [1] ANDERSEN LJ, 1992, J OTOLARYNGOL, V21, P180
  • [2] Ballow M, 2001, CLIN REV ALLERG IMMU, V20, P1, DOI 10.1385/CRIAI:20:1:1
  • [3] THE PATHOLOGY OF HEAD AND NECK TUMORS - MUCOSAL MELANOMAS .13.
    BATSAKIS, JG
    REGEZI, JA
    SOLOMON, AR
    RICE, DH
    [J]. HEAD & NECK SURGERY, 1982, 4 (05): : 404 - 418
  • [4] BERTHELSEN A, 1984, CANCER, V54, P907, DOI 10.1002/1097-0142(19840901)54:5<907::AID-CNCR2820540526>3.0.CO
  • [5] 2-Z
  • [6] CLINICAL AND PATHOLOGICAL DISTINCTION BETWEEN PRIMARY AND METASTATIC MUCOSAL MELANOMA OF THE HEAD AND NECK
    BILLINGS, KR
    WANG, MB
    SERCARZ, JA
    FU, YS
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1995, 112 (06) : 700 - 706
  • [7] Brandwein MS, 1997, ARCH OTOLARYNGOL, V123, P290
  • [9] BRIELE HA, 1985, CLIN PLAST SURG, V12, P495
  • [10] MUCOSAL MELANOMAS OF HEAD AND NECK
    CATLIN, D
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1967, 99 (04): : 809 - &